Hailed as one of the most significant achievements in the field of science, the Mendeleev Periodic Table of Chemical Elements is celebrating its 150th anniversary in 2019. Not only has it revolutionised the way...
When the engines of a plane rev up and we are momentarily plunged into our seats, chances are that propulsion is due to a gas turbine. Although these energy generators are fundamental to industry, especially to aeronautics, their production of harmful exhaust gases is a cause of concern. ERC grantee Aimee Morgans works on making gas turbines greener.
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancer
Pancreatic cancer is the 4th leading cause of death by cancer in Europe. It has a very low survival rate with less than 1 per cent of sufferers surviving for 10 or more years. Over the last 40 years the survival rate has not significantly changed and finding an effective therapy has become a pressing challenge in cancer research. A team based at Imperial College London led by Armando Del Río Hernández, has now demonstrated that a well-known drug could be effective to fight this deadly and other forms of cancer, such as liver cancer.
Cancer is one of the most challenging medical issues we face. In the United Kingdom alone, there are 300,000 new cases every year – leading to almost two million surgical operations annually. Thanks to ERC funding, Dr Zoltán Takáts of Imperial College London has developed a ‘smart’ surgical knife that can ‘smell’ the tissues it is cutting through – with the potential to revolutionise cancer treatment, as well as food and drug analysis, and research into the human ‘microbiome’.